NO820399L - Cysteinavgivende system - Google Patents

Cysteinavgivende system

Info

Publication number
NO820399L
NO820399L NO820399A NO820399A NO820399L NO 820399 L NO820399 L NO 820399L NO 820399 A NO820399 A NO 820399A NO 820399 A NO820399 A NO 820399A NO 820399 L NO820399 L NO 820399L
Authority
NO
Norway
Prior art keywords
cysteine
carboxylate
oxothiazolidine
oxo
glutathione
Prior art date
Application number
NO820399A
Other languages
English (en)
Norwegian (no)
Inventor
Alton Meister
Joanne M Williamson
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Publication of NO820399L publication Critical patent/NO820399L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/12—Methionine; Cysteine; Cystine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Threshing Machine Elements (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO820399A 1981-02-11 1982-02-10 Cysteinavgivende system NO820399L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/233,564 US4335210A (en) 1981-02-11 1981-02-11 Method of producing L-cysteine

Publications (1)

Publication Number Publication Date
NO820399L true NO820399L (no) 1982-08-12

Family

ID=22877749

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820399A NO820399L (no) 1981-02-11 1982-02-10 Cysteinavgivende system

Country Status (8)

Country Link
US (1) US4335210A (da)
EP (1) EP0057942B1 (da)
JP (1) JPS57188513A (da)
AT (1) ATE15445T1 (da)
CA (1) CA1167766A (da)
DE (1) DE3266087D1 (da)
DK (1) DK48882A (da)
NO (1) NO820399L (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647571A (en) * 1981-02-11 1987-03-03 Cornell Research Foundation Cysteine delivery composition
CH654302A5 (de) * 1983-05-04 1986-02-14 Sandoz Ag Acylaminophenolderivate, ihre herstellung und arzneimittel, welche sie enthalten.
US4868114A (en) * 1987-08-05 1989-09-19 Regents Of The University Of Minnesota Method for elevating glutathione levels
ATE119038T1 (de) * 1988-12-09 1995-03-15 Allergan Inc Verwendung von 2-substituierten thiazolidin-4- carbonsäuren zur behandlung von katarakt.
CA1339256C (en) * 1989-01-26 1997-08-12 Wulf Droge Treatment of diseases associated with hiv-infections
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
JP2769243B2 (ja) * 1990-02-19 1998-06-25 ノボ ノルディスク アクティーゼルスカブ 溶液、特に発酵溶液から精製ｅｐｉ蛋白質の回収方法
ES2092539T3 (es) * 1991-01-10 1996-12-01 Transcend Therapeutics Inc Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares.
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
ATE137968T1 (de) * 1991-09-30 1996-06-15 Transcend Therapeutics Inc Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
AU661379B2 (en) * 1992-04-23 1995-07-20 Transcend Therapeutics, Inc Method of reducing or preventing toxicity associated with antiretroviral therapy
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
US5589464A (en) * 1992-09-01 1996-12-31 Allergan Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract
AU5040493A (en) 1992-11-30 1994-06-09 Transcend Therapeutics, Inc Method for treating systemic inflammatory response syndrome
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
FR2742658B1 (fr) * 1995-12-22 1998-01-30 Oreal Utilisation de la procysteine comme agent depigmentant
US5780489A (en) * 1996-08-21 1998-07-14 Brooks; Benjamin Rix Method for treating amyotrophic lateral sclerosis
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
EP1257273A2 (en) 1999-08-17 2002-11-20 University of Saskatchewan Technologies Inc. Improved treatment for acute physical insult to the central nervous system
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
US20060105972A1 (en) * 2004-11-17 2006-05-18 Nagasawa Herbert T Method to enhance delivery of glutathione and ATP levels in cells
TW201201712A (en) * 2010-01-28 2012-01-16 Max International Llc Compositions comprising sugar-cysteine products
TW201202209A (en) * 2010-01-28 2012-01-16 Max International Llc Methods of preparing thiazolidines
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034536A1 (en) * 1969-02-11 1970-12-11 Academia Republ Roman A Thiazolidinecarboxylic acid-4derivs
US3974031A (en) * 1974-05-09 1976-08-10 Mitsubishi Chemical Industries Ltd. Process for producing L-cysteine or its derivatives
US4006057A (en) * 1974-11-06 1977-02-01 Ajinomoto Co., Inc. Method of producing L-cysteine and L-cystine
JPS5272883A (en) * 1975-12-12 1977-06-17 Ajinomoto Co Inc Preparation of sulfur-containing amino acid
US4384001A (en) * 1978-12-21 1983-05-17 Gosalvez Mario Treatment of tumors with thiazolidine-4-carboxylic acid

Also Published As

Publication number Publication date
JPS57188513A (en) 1982-11-19
DK48882A (da) 1982-08-12
EP0057942A3 (en) 1982-10-27
EP0057942A2 (en) 1982-08-18
EP0057942B1 (en) 1985-09-11
ATE15445T1 (de) 1985-09-15
US4335210A (en) 1982-06-15
DE3266087D1 (en) 1985-10-17
CA1167766A (en) 1984-05-22

Similar Documents

Publication Publication Date Title
NO820399L (no) Cysteinavgivende system
US4438124A (en) Cysteine delivery system
US4665082A (en) Cysteine delivery system
US4647571A (en) Cysteine delivery composition
Kaziro et al. The metabolism of propionic acid.
Williamson et al. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate.
US4434158A (en) Cysteine delivery system
US4434160A (en) Nutrient solution for complete parenteral feeding and for increased energy production
Windmueller et al. Uptake and metabolism of plasma glutamine by the small intestine
Lu Regulation of glutathione synthesis
Olney et al. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine
KR890002948B1 (ko) 수액제의 갈변 방지방법
Van Der Werf et al. Accumulation of 5-oxoproline in mouse tissues after inhibition of 5-oxoprolinase and administration of amino acids: evidence for function of the γ-glutamyl cycle
Thompson et al. Utilization of L-cystine by the gamma-glutamyl transpeptidase-gamma-glutamyl cyclotransferase pathway.
US4758551A (en) Methods for combatting renal toxicity due to metals or nephrotoxic drugs and for selectively modulating in vivo formation of leukotriene types
Kaukel et al. Divergent action of cAMP and dibutyryl cAMP on macromolecular synthesis in HeLa S3 cultures
Rognstad Sources of ammonia for urea synthesis in isolated rat liver cells
Yudkoff et al. Glutamate dehydrogenase reaction as a source of glutamic acid in synaptosomes
Hilz et al. Divergent action mechanism of cAMP and dibutyryl cAMP on cell proliferation and macromolecular synthesis in HeLa S3 cultures
IL258487B2 (en) Preparations and methods for the treatment of excessive homocysteine in the urine
Hasebe et al. Glutamate in enteral nutrition: can glutamate replace glutamine in supplementation to enteral nutrition in burned rats?
CJ Biochemical changes in thiamine deficiencies
Borrebaek Adaptable hexokinase activity in epididymal adipose tissue studied in vivo and in vitro
Okamoto Influence of L-thyroxine on kynurenine 3-hydroxylase, monoamine oxidase, and rotenone-insensitive NADH-cytochrome c reductase in mitochondrial outer membrane
Randle et al. 4 Branched-Chain Ketoacid Dehydrogenase